Skip to main content

Not all doom and gloom for Latin America

The positive news on the efficacy of COVID-19 vaccines offers hope for the region’s economy. As things stand, Chile and, to a lesser extent, Mexico look well placed to benefit given their sizeable pre-orders. Purchases are relatively small in Peru and Colombia, suggesting these economies may be slower to receive a ‘vaccine bounce’. Of course, there will be many logistical and distributional challenges to rolling out a vaccine, suggesting an economic boost may only come in the second half of 2021. And in the meantime, the regional economic recovery will continue to be weighed down by the continued spread of the virus. But the key point is that a vaccine offers a much-needed route out of the coronavirus-related slump for most economies in the region.

Subscriber content

Read this in full, free

Start a free trial and use one of your 10 free starter credits to unlock this piece.


Free. 10 articles. No card required.

By completing this form you are agreeing to our Terms and Conditions for the provision of a free trial of Capital Economics' services. We take your privacy seriously and will not share your details with others without your consent. By providing your details, including your email address, you are consenting to Capital Economics sending you macroeconomic commentary and analysis. You can unsubscribe at any time. See our Privacy Policy for more information.